Impax Acquires Generic Products From Teva and Allergan


Impax has acquired a portfolio of generic products from Allergan and Teva. The products include drugs in solid oral, inhalable, injectable, and topical dosage forms. The total price tag for the acquisition is about $586 million. The deal is being financed with $400 million in new fully committed term loans and existing cash.

Read the source article at PR Newswire

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>